Larson Financial Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
1WCM
Larson Financial Group's MRVI Position: Q3 2026 in Review
Larson Financial Group opened a new position in Maravai LifeSciences (MRVI) in Q3 2026: 1,808 shares worth $13.8K. The stake represents ﹤0.01% of the portfolio and ranks #2340 among its holdings. This is a return to the name: Larson Financial Group previously reported a position in MRVI as recently as Q4 2024.
Larson Financial Group first reported a position in MRVI in Q3 2024 and has held it in 3 quarters since. The position peaked at $15.7K in Q4 2024. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- Larson Financial Group held 1,808 shares of Maravai LifeSciences worth $13.8K as of Q3 2026.
- Maravai LifeSciences was a new Larson Financial Group position in Q3 2026.
- Maravai LifeSciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2340 holding.
- Larson Financial Group first reported a position in Maravai LifeSciences in Q3 2024 and has held it in 3 quarters since.
- Larson Financial Group's Maravai LifeSciences position peaked at $15.7K in Q4 2024.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.